Advertisement

Related Videos

Cody Peer, PhD, on Simulating Alternative Schedules for Checkpoint Inhibitors

Kelvin Chan, MD, FRCPC, MSc, PhD, on Opportunities to Optimize Cancer Drug Policies: The Canadian Perspective

Peter Clark, MA, MD, FRCP: A Payer Perspective

Boon-Cher Goh, MD, on Cancer Drugs in Singapore: 3As (Availability, Accessibility, and Affordability)

David A. Hyman, MD, JD, on Inclusive Shared Savings

Advertisement

Advertisement




Jan
16
Today In Oncology
Triplet Therapy Demonstrates Superior Progression-Free Survival in First-Line dMMR-MSI-H Metastatic Colorectal Cancer
Can Multimodal AI Models Predict Distant Recurrence Risk in Patients With Early Breast Cancer
HER2-Positive Gastroesophageal Cancer Zanidatamab Plus Chemotherapy Prolongs Progression-Free Survival
Improved Contralateral Breast Cancer Risk Knowledge With Personalized Counseling Tool
Machine Learning–Guided Optical Biopsy Accurately Identifies Malignant Lung Nodules Intraoperatively
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo